Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 507091, 9 pages
http://dx.doi.org/10.1155/2013/507091
Research Article

Functional Recovery after Scutellarin Treatment in Transient Cerebral Ischemic Rats: A Pilot Study with 18F-Fluorodeoxyglucose MicroPET

Jin-hui Li,1,2,3,4,5 Jing Lu,6 and Hong Zhang1,3,4,5

1Department of Nuclear Medicine, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China
2Department of Traditional Chinese Medicine & Rehabilitation, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China
3Zhejiang University Medical PET Center, Hangzhou, Zhejiang 310009, China
4Institute of Nuclear Medicine and Molecular Imaging of Zhejiang University, Hangzhou, Zhejiang 310009, China
5Key Laboratory of Medical Molecular Imaging of Zhejiang Province, Hangzhou, Zhejiang 310009, China
6Department of Neurobiology, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China

Received 28 February 2013; Accepted 12 April 2013

Academic Editor: Mei Tian

Copyright © 2013 Jin-hui Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Wan, H. Zhu, M. Tian et al., “Protective effect of chuanxiongzine-puerarin in a rat model of transient middle cerebral artery occlusion-induced focal cerebral ischemia,” Nuclear Medicine Communications, vol. 29, no. 12, pp. 1113–1122, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Yang, J. Li, J. Lu et al., “Synergistic protective effect of astragaloside IV-tetramethylpyrazine against cerebral ischemic-reperfusion injury induced by transient focal ischemia,” Journal of Ethnopharmacology, vol. 140, no. 1, pp. 64–72, 2012. View at Google Scholar
  3. L. L. Guo, Z. Z. Guan, and Y. L. Wang, “Scutellarin protects against Abeta-induced learning and memory deficits in rats: involvement of nicotinic acetylcholine receptors and cholinesterase,” Acta Pharmacologica Sinica, vol. 32, no. 12, pp. 1446–1453, 2011. View at Google Scholar
  4. L. L. Lin, A. J. Liu, J. G. Liu, X. H. Yu, L. P. Qin, and D. F. Su, “Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats,” Journal of Cardiovascular Pharmacology, vol. 50, no. 3, pp. 327–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. G. H. Zhang, Q. Wang, J. J. Chen, X. M. Zhang, S. C. Tam, and Y. T. Zheng, “The anti-HIV-1 effect of scutellarin,” Biochemical and Biophysical Research Communications, vol. 334, no. 3, pp. 812–816, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Su, W. Liu, L. Ma et al., “Scutellarin inhibits translocation of protein kinase C in diabetic thoracic aorta of the rat,” Clinical and Experimental Pharmacology & Physiology, vol. 39, no. 2, pp. 136–140, 2012. View at Google Scholar
  7. G. Zhang, S. Qiu, and H. Wei, “Scutellarin blocks sodium current in freshly isolated mouse hippocampal CA1 neurons,” Neurochemical Research, vol. 36, no. 6, pp. 947–954, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Wang, H. Wang, H. Guo, L. Kang, X. Gao, and L. Hu, “Neuroprotection of Scutellarin is mediated by inhibition of microglial inflammatory activation,” Neuroscience, vol. 185, pp. 150–160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. H. F. Zhang, X. M. Hu, L. X. Wang, S. Q. Xu, and F. D. Zeng, “Protective effects of scutellarin against cerebral ischemia in rats: evidence for inhibition of the apoptosis-inducing factor pathway,” Planta Medica, vol. 75, no. 2, pp. 121–126, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Liu, X. Yang, R. Tang, J. Liu, and H. Xu, “Effect of scutellarin on nitric oxide production in early stages of neuron damage induced by hydrogen peroxide,” Pharmacological Research, vol. 51, no. 3, pp. 205–210, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Li, C. S. Piao, X. Y. Liu et al., “Brain self-protection: the role of endogenous neural progenitor cells in adult brain after cerebral cortical ischemia,” Brain Research, vol. 1327, pp. 91–102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Nakagomi, T. Nakagomi, S. Kubo et al., “Endothelial cells support survival, proliferation, and neuronal differentiation of transplanted adult ischemia-induced neural stem/progenitor cells after cerebral infarction,” Stem Cells, vol. 27, no. 9, pp. 2185–2195, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Li, Q. Jiang, G. Ding et al., “Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study,” Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 3, pp. 653–662, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Zhao, Q. Jiao, X. Chen et al., “mGluR5 is involved in proliferation of rat neural progenitor cells exposed to hypoxia with activation of mitogen-activated protein kinase signaling pathway,” Journal of Neuroscience Research, vol. 90, no. 2, pp. 447–460, 2012. View at Google Scholar
  15. X. Xu, J. Zhang, X. Chen et al., “The increased expression of metabotropic glutamate receptor 5 in subventricular zone neural progenitor cells and enhanced neurogenesis in a rat model of intracerebral hemorrhage,” Neuroscience, vol. 202, pp. 474–483, 2012. View at Google Scholar
  16. C. C. Shen, Y. C. Yang, M. T. Chiao, W. Y. Cheng, Y. S. Tsuei, and J. L. Ko, “Characterization of endogenous neural progenitor cells after experimental ischemic stroke,” Current Neurovascular Research, vol. 7, no. 1, pp. 6–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Minnerup, J. B. Kim, A. Schmidt et al., “Effects of neural progenitor cells on sensorimotor recovery and endogenous repair mechanisms after photothrombotic stroke,” Stroke, vol. 42, no. 6, pp. 1757–1763, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. M. Osman, M. J. Porritt, M. Nilsson, and H. G. Kuhn, “Long-term stimulation of neural progenitor cell migration after cortical ischemia in mice,” Stroke, vol. 42, no. 12, pp. 3559–3565, 2011. View at Google Scholar
  19. Y. Gürsoy-Özdemir, A. Can, and T. Dalkara, “Reperfusion-induced oxidative/nitrativie injury to neurovascular unit after focal cerebral ischemia,” Stroke, vol. 35, no. 6, pp. 1449–1453, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. H. Ran and H. Wang, “Iptakalim, an ATP-sensitive potassium channel opener, confers neuroprotection against cerebral ischemia/reperfusion injury in rats by protecting neurovascular unit cells,” Journal of Zhejiang University Science B, vol. 12, no. 10, pp. 835–845, 2011. View at Google Scholar
  21. X. Zhang, J. A. Winkles, M. C. Gongora et al., “TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 27, no. 3, pp. 534–544, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Yamashita, T. Kamiya, K. Deguchi et al., “Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 4, pp. 715–725, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Hayakawa, T. Nakano, K. Irie et al., “Inhibition of reactive astrocytes with fluorocitrate retards neurovascular remodeling and recovery after focal cerebral ischemia in mice,” Journal of Cerebral Blood Flow and Metabolism, vol. 30, no. 4, pp. 871–882, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Arvidsson, T. Collin, D. Kirik, Z. Kokaia, and O. Lindvall, “Neuronal replacement from endogenous precursors in the adult brain after stroke,” Nature Medicine, vol. 8, no. 9, pp. 963–970, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Gao, R. Liu, S. Y. Zhu, and G. H. Du, “Acute neurovascular unit protective action of pinocembrin against permanent cerebral ischemia in rats,” Journal of Asian Natural Products Research, vol. 10, no. 6, pp. 551–558, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Qin, J. B. Wang, W. J. Kong et al., “The diarrhoeogenic and antidiarrhoeal bidirectional effects of rhubarb and its potential mechanism,” Journal of Ethnopharmacology, vol. 133, no. 3, pp. 1096–1102, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. J. B. Wang, H. P. Zhao, Y. L. Zhao et al., “Hepatotoxicity or hepatoprotection? Pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury,” PLoS One, vol. 6, no. 9, Article ID e24498, 2011. View at Google Scholar
  28. E. Z. Longa, P. R. Weinstein, S. Carlson, and R. Cummins, “Reversible middle cerebral artery occlusion without craniectomy in rats,” Stroke, vol. 20, no. 1, pp. 84–91, 1989. View at Google Scholar · View at Scopus
  29. J. Chen, P. R. Sanberg, Y. Li et al., “Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats,” Stroke, vol. 32, no. 11, pp. 2682–2688, 2001. View at Google Scholar · View at Scopus
  30. X. D. Chao, F. Fei, and Z. Fei, “The role of excitatory amino acid transporters in cerebral ischemia,” Neurochemical Research, vol. 35, no. 8, pp. 1224–1230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Liu, S. Mituska, K. Hashizume, T. Hosaka, and H. Nukui, “The time course of glucose metabolism in rat cerebral ischemia with middle cerebral artery occlusion-reperfusion model and the effect of MK-801,” Neurological Research, vol. 18, no. 6, pp. 505–508, 1996. View at Google Scholar · View at Scopus
  32. T. Nelson, E. E. Kaufman, and L. Sokoloff, “2-Deoxyglucose incorporation into rat brain glycogen during measurement of local cerebral glucose utilization by the 2-deoxyglucose method,” Journal of Neurochemistry, vol. 43, no. 4, pp. 949–956, 1984. View at Google Scholar · View at Scopus
  33. Y. Liu, S. Mituska, K. Hashizume, T. Hosaka, and H. Nukui, “The sequential change of local cerebral blood flow and local cerebral glucose metabolism after focal cerebral ischaemia and reperfusion in rat and the effect of MK-801 on local cerebral glucose metabolism,” Acta Neurochirurgica, vol. 139, no. 8, pp. 770–779, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. M. He, Z. M. Xue, J. Li, and B. Q. Zhou, “Breviscapine inhibits high glucose-induced proliferation and migration of cultured vascular smooth muscle cells of rats via suppressing the ERK1/2 MAPK signaling pathway,” Acta Pharmacologica Sinica, vol. 33, no. 5, pp. 606–614, 2012. View at Google Scholar
  35. Y. Liu, S. Mituska, K. Hashizume, T. Hosaka, and H. Nukui, “The time course of glucose metabolism in rat cerebral ischemia with middle cerebral artery occlusion-reperfusion model and the effect of MK-801,” Neurological Research, vol. 18, no. 6, pp. 505–508, 1996. View at Google Scholar · View at Scopus
  36. M. Lou, H. Zhang, J. Wang et al., “Hyperbaric oxygen treatment attenuated the decrease in regional glucose metabolism of rats subjected to focal cerebral ischemia: a high resolution positron emission tomography study,” Neuroscience, vol. 146, no. 2, pp. 555–561, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. W. Xu, R. P. Zha, W. Y. Wang, and Y. P. Wang, “Effects of scutellarin on PKCγ in PC12 cell injury induced by oxygen and glucose deprivation,” Acta Pharmacologica Sinica, vol. 28, no. 10, pp. 1573–1579, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. L. X. Wang, J. P. Zeng, X. B. Wei, F. W. Wang, Z. P. Liu, and X. M. Zhang, “Effects of scutellarin on apoptosis induced by cobalt chloride in PC12 cells,” The Chinese Journal of Physiology, vol. 50, no. 6, pp. 301–307, 2007. View at Google Scholar · View at Scopus
  39. H. Hong and G. Q. Liu, “Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin,” Life Sciences, vol. 74, no. 24, pp. 2959–2973, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Liu, X. L. Yang, Y. Wang, X. Q. Tang, D. Y. Jiang, and H. B. Xu, “Protective effects of scutellarin on superoxide-induced oxidative stress in rat cortical synaptosomes,” Acta Pharmacologica Sinica, vol. 24, no. 11, pp. 1113–1174, 2003. View at Google Scholar · View at Scopus
  41. H. F. Zhang, X. M. Hu, L. X. Wang, S. Q. Xu, and F. D. Zeng, “Protective effects of scutellarin against cerebral ischemia in rats: evidence for inhibition of the apoptosis-inducing factor pathway,” Planta Medica, vol. 75, no. 2, pp. 121–126, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. L. L. Lin, A. J. Liu, J. G. Liu, X. H. Yu, L. P. Qin, and D. F. Su, “Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats,” Journal of Cardiovascular Pharmacology, vol. 50, no. 3, pp. 327–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Mykkänen, M. Juhola, and U. Ruotsalainen, “Three-dimensional ROIs in brain PET,” Studies in Health Technology and Informatics, vol. 68, pp. 339–342, 1999. View at Google Scholar · View at Scopus
  44. E. Planel, T. Miyasaka, T. Launey et al., “Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease,” Journal of Neuroscience, vol. 24, no. 10, pp. 2401–2411, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Zhang, X. Zheng, X. Yang et al., “11C-NMSP/18F-FDG microPET to monitor neural stem cell transplantation in a rat model of traumatic brain injury,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 9, pp. 1699–1708, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Rex, P. T. Meyer, J. H. Baumert et al., “Positron emission tomography study of regional cerebral blood flow and flow-metabolism coupling during general anaesthesia with xenon in humans,” British Journal of Anaesthesia, vol. 100, no. 5, pp. 667–675, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. A. K. Håberg, H. Qu, and U. Sonnewald, “Acute changes in intermediary metabolism in cerebellum and contralateral hemisphere following middle cerebral artery occlusion in rat,” Journal of Neurochemistry, vol. 109, supplement 1, pp. 174–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. S. J. Chmura, M. E. Dolan, A. Cha, H. J. Mauceri, D. W. Kufe, and R. R. Weichselbaum, “In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo,” Clinical Cancer Research, vol. 6, no. 2, pp. 737–742, 2000. View at Google Scholar · View at Scopus
  49. Y. Liu, M. V. Cohen, and J. M. Downey, “Chelerythrine, a highly selective protein kinase C inhibitor, blocks the antiinfarct effect of ischemic preconditioning in rabbit hearts,” Cardiovascular Drugs and Therapy, vol. 8, no. 6, pp. 881–882, 1994. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Saito and Y. Shirai, “Protein kinase Cγ (PKCγ): function of neuron specific isotype,” Journal of Biochemistry, vol. 132, no. 5, pp. 683–687, 2002. View at Google Scholar · View at Scopus
  51. U. Ito, Y. Hakamata, E. Kawakami, and K. Oyanagi, “Temporary focal cerebral ischemia results in swollen astrocytic end-feet that compress microvessels and lead to focal cortical infarction,” Journal of Cerebral Blood Flow and Metabolism, vol. 31, no. 1, pp. 328–338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Michaelides, J. Pascau, J. D. Gispert et al., “Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate,” European Journal of Neuroscience, vol. 32, no. 4, pp. 668–676, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. G. Barreto, R. E. White, Y. Ouyang, L. Xu, and R. G. Giffard, “Astrocytes: targets for neuroprotection in stroke,” Central Nervous System Agents in Medicinal Chemistry, vol. 11, no. 2, pp. 164–173, 2011. View at Google Scholar · View at Scopus
  54. M. Pekny, C. Eliasson, R. Siushansian et al., “The impact of genetic removal of GFAP and/or vimentin on glutamine levels and transport of glucose and ascorbate in astrocytes,” Neurochemical Research, vol. 24, no. 11, pp. 1357–1362, 1999. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Mabuchi, J. Lucero, A. Feng, J. A. Koziol, and G. J. Del Zoppo, “Focal cerebral ischemia preferentially affects neurons distant from their neighboring microvessels,” Journal of Cerebral Blood Flow and Metabolism, vol. 25, no. 2, pp. 257–266, 2005. View at Publisher · View at Google Scholar · View at Scopus